112 3-3-1ȁë¨ƭŭƸƍǾCBCǿ
[w^ev{Ơ06T{`y}wƠ1ŏNJ#/&E5DZŻ4/>ĴĒ3 à¼6<BE3-*Ǿư4-eǿ
3-3-2ȁů¼éŹŅĿA7ǭƶdžŅĿ
[w^ev{Ơ06T{`y}wƠ1ŏNJ#/&E5DZŻ4/>ĴĒ3 à¼6<BE3-*Ǿư4-fǿ
3-4ȁƭØŅĿ
[w^ev{Ơ06SAPMAPA7 DAP &E4/>T{`y}wƠ 1ŏNJ#/&E5DZŻ4/>ĴĒ3à¼6<BE3-*Ǿư4-gǿ
113
AT 1`y{f{GƖ7.Dƥ¶ŚĄ#/D!1žBE/D.;C LMWH6FXaGĆĜ±%DĞ`y{f{Ű6Ą*=UFHAC¬ƭ5µ
Űô3Ƭ´0DǾ109ǿ
[w^ev{Ơ06ČĘƭ5AR\]j4/OT6²Š³1ŏNJ#/ĴĒ3 à¼6ƿ=BE&~DŽ#/ſƞ¦ÎGƂ#*;;0CT{`y}wƠ1Ƕ#*
Ĥº0-*##[w^ev{Ơ5ĭOT5ſƞū6ljÿ%3F,T{`
y}wƠAC>OTǟ²ŠȂǓĉ4Ơǡ5ĴĒøƿ=BE*[w^ev{
6AT G#/ 4ŖĎÛƋXÓçǾ4ŖĎÛƋIXXIXÓç`y{f {ǿGǤî%D!10Af4AD«×Óç5ŖĎ¼GĜ/D!1žBE/D Ǿ110ǿ²Š1Ǔĉ4/Ơǡ5ĴĒøƿ=BE*56!5[w^ev{5Ĝ
±Ű1Ǔĉ5ıŢ06¹ľ-*!14AD1Ĩś"E*##ƘıŹ4
«×Óç5ŖĎß#/!14A-/[w^ev{5Ğ«×Ű06ĜE3 3CijƓŹ46T{`y}wƠ1Í$Ƈÿ;0OTſƞ#*1ƢBE*AUC 6OT1ǒº#/ĨƆ%Deur}Z}0COTſƞ%D1AUC 6(E4-/߸%D#*-/[w^ev{Ơ5AUC6²Š1Ǔĉ4T{`y}wƠ 1ŏ9/(5߸ĜBE*!10Ơǡ5ĴĒøƿ=BEijƓŹ4²Š3Ǔĉ 4/6T{`y}wƠ1Ǎ4ĨƆ#*1ƢBE*
[w^ev{Ơ5ČĘƭ5 PL \]j6Ơǡ4/ĴĒøƿ=BE3-*
*=ƭóļ4ñ%DŰ6ƿ=BE31ƢBE*;*APTT 6T{`y}
wƠ1ŵ3Cāǟ'&ĴĒ3à¼>ƿ=BE3-*!5!16[w^ev{
ŖĎÛ«×ÓçǾ 4ƋXÓçǿ5ŖĎGǤî%D!10(5«×ÓçAC>N XR}a54Ɵ%D«×ÓçŎè#/CijƓŹ4T{`y}wƠ1Í$
xlw;0«×Óç5ŖĎ-*1#/>APTT 5āǟG*%:2;0«×
ÓçŗDž"E3-*!14AD1ƢBE*
5A4[w^ev{Ơ06ČĘƭ5AR\]j6²Š1Ǔĉ4/ĴĒ øƿ=BE*(5ĉ6ſƞ¦Î;*APTT 4Ǣ#/6ĴĒ3à¼6ƿ=B
114
E3-*APTT 4Ǣ#/6Ơ4/¨/ÁƢ©0ĨƆ#/D!1 BAPTT 5śìƖľGǎ5<06íǧ5ƭŘĎŨGŌƁ4ěĩ%D!1ÔǬ 0C[w^ev{4ADœŸ¹ľ5scZv{Q46Ǘ®0D1ƢBE*
;*[w^ev{Ơ5ķńƭ5 PL5 OT4/T{`y}wƠ1ŏNJ#/
[w^ev{Ơ4ĴĒ3āǟƿ=BE*!5!16ĸĺ«×Ĝ±ŰGģ.
[w^ev{ƭóļ4ñ#/>Ĝ±¹ľGƂ#*1!1GƂÐ#/D[
w^ev{6ĸĺĞ«×Ƭ0C 1#/«×Óç4ñ#/5ŰGƂ#ƭó ļ4ñ%DĜ±Ű6ô31ƷFE/*ƭóļŊƥ4ñ%DŰ>ƿ=BE D15ÝÏƳÅBEDǾ111, 112ǿ!5!1BÒ5[w^ev{5ƭóļ ŊƥGƽ%D PL 5āǟ<BE*50631ƢBE*##ČĘ©4 D PL 06¨/5ıŢ4/ĴĒ3à¼ƿ=BE3-*!1BČĘ
©06ĞƭóļŰGƂ%:25ĆŰ63!1¯İ#*
5!1BĸíǸ5ƖľB Af ı4ñ#/[w^ev{5¿ũĝ06 2 ǓŻǥ5 Af 4AD«×Óç5ŖĎGĜD!103*=ĝĭŔ5àIJ ǾǮƦ©ĝ?ĝƬǝǿ?5ƭŁœŸƬ15Ű32ªƢ%9ŢD1ƢB E*;*ǐú5 Af 5ƩýŶ6Ȩ4-/ů$D!1âíǸı5 Af s_wŧ5ČĘ©ź4ŏ9(5¥î5Ƈÿ6ACŠ#!1đ"ED*=
"B3DœŸėųŐ=BED;*[w^ev{5<0å·#3-*ƲÓ1#
/1ŧ4DAfűĺ5ƭŁĖ6«×Óç1ƭóļÓç5ĭǢF-/
D>55ËƭŁĖ5ŖĎA7ƭŁ5ƔĖŵ3DÈƥĎ>Ĩś"E*(5*
=ĉ6ĞƭóļƬ0DPygaQxw15Ű?żħƕÆĞ«×ƬǾDOACǿ 4DĞƭŁœŸ¹ľA7ČĘŊƥ5ĪÑG»Ń#*œŸ5ŰGŅƹ%Dč ƲD1ƢBE*
115
5. óĢ
Ƌ3Ɗ5ĔĎĵČĘ²ŠƠGT{`y}wƠ1#/ŰƩýŬÞ0őŰ"E/DĞ«×Ƭ0D[w^ev{GǀĿñǃƬ1#/Afs_wŧ4ñ#3Ǔǡ4F*
Cĝ#*(5Ɩľ[w^ev{Ơ06ČĘƭ5AR\]j4/OT6² Š³1ŏNJ#/ĴĒ3à¼6ƿ=BE&~DŽ#/ſƞ¦ÎGƂ#*;;0CT{
`y}wƠ1Ƕ#*Ĥº0-*##[w^ev{Ơ5ĭ OT 5ſƞū6 ljÿ%3F,T{`y}wƠAC> OT ǟ²ŠȂǓĉ4Ơǡ5ĴĒøƿ=
BE*
[w^ev{6AT G#/ 4ŖĎÛƋX ÓçǾ4ŖĎÛƋIXXIX Óç`y{f{ǿGǤî%D!10Af4AD«×Óç5ŖĎ¼GĜ/D!1 žBE/D²Š1Ǔĉ4/Ơǡ5ĴĒøƿ=BE*56!5[w^e v{5Ĝ±Ű1Ǔĉ5ıŢ06¹ľ-*!14AD1Ĩś"E*##
ƘıŹ4«×Óç5ŖĎß#/!14A-/[w^ev{5Ğ«×Ű06Ĝ E33CijƓŹ46T{`y}wƠ1Í$Ƈÿ;0 OT ſƞ#*1ƢB E*
ÒȀ[w^ev{5ĝ4>FB&ČĘƭ4DƭŘŋƭŊƥǾ«×Ó çƐ1ƭóļŊƥ5Âĭǿ5ǔĜ±03-*Ůű1#/AfŨēģƙ#/
D*=ČĘ©4DƒƤǨî?ƭŘǺŞĊ4ǔƮ#(E4«×ƥ>
ǔ#**=²Š 1 ǓŻ;0Ĝ±Èƥ0-*«×Óç5ŖĎȀƬ´5Ğ«×
ŰGÒ-**=0D1Ĩð#*(5*=Ȁŧ5Af ı5ƭŁǣ|œŸ1#/Ȁ ĞƭŘ«×œŸ5<03ȀĞƭóļƬ0DPygaQxw15Ű?żħƕÆ Ğ«×ƬǾDOACǿ4DĞƭŁœŸ¹ľA7ČĘŊƥ5ĪÑG»Ń#*œŸ 5ŰGŅƹ%DčƲD1Ɩǁ*
116
6. Y«
Y4-a.e¿7C/%EA %D/CEA¥~¸²t¨Fx+A.3@D¥9E'D#·`W{®¿I +A.3@DÁ+A.3@D0/@=5?#<DºÄ5&EmKJÂ150 IU/kgTIDÁ8{ 16{24{ÂHgªoÀ¾lpsQR(Pre)Q·`1³o (1w)2³o (2w)3³o (3w) V{T-TAS ©OZ§ © ey117
Y4-bÃps©AR,-7OT¡{_S VdLk\L± Mj«Ä%D/CEA¥±p<0.05}rj Cont: %D/CEA¥Án=8ÂDaltepa:+A.3@D¥Án=7Âpre: À¾lpsQR1w: psQ1³o2w: psQ2³o3wÄp sQ3³oARÄ©h§OZ§d,-7OT:¶^{¸
0 100
200
300
400 pre 1w 2w 3w Cont Daltepa
(sec)
118
Y4-cÃps©PL,-7OT¡{_S VdLk\L± Mj« Cont:%D/CEA¥Án=8ÂDaltepa: +A.3@D¥Án=7Âpre: À¾lpsQR1w: psQ1³o2w: psQ2³o3wÄp sQ3³oPLÄ©h§d,-7OT:¶^{¸
0 100
200
300
400
500 pre 1w 2w 3w Cont Daltepa
(sec)
119
Y4-déAR,-7OT¡{_S VdLk\L± Mj« Cont: %D/CEA¥Án=8ÂDaltepa:+A.3@D¥Án=7Âpre: À¾lpsQR1w: psQ1³o2w: psQ2³o3wÄ psQ3³oARÄ©h§OZ§d,-7OT:¶^{¸
0 100
200
300
400 pre 1w 2w 3w Cont Daltepa
(sec)
120
Y4-eéPL,-7OT¡{_S VdLk\L± Mj«Ä%D/CEA¥±p<0.05}rj Cont:%D/CEA¥Án=8ÂDaltepa: +A.3@D¥Án=7Âpre: À¾lpsQR1w: psQ1³o2w: psQ2³o3wÄp sQ3³oPLÄ©h§d,-7OT:¶^{¸
0 100
200
300
400
500 pre 1w 2w 3w Cont Daltepa
(sec)
121
«4-aÃps©T-TAS¡{_S VdLk\L± Mj«: %D/CEA¥±p<0.05}rj T10 : ¶^·`{¸OT :¶^{¸AUC :[Gz|£H´½]»PL:AR: pre: À¾lpsQR1w: psQ1³¸o2w: psQ2³¸o3wÄpsQ3³¸o
122
«4-béT-TAS¡{_S VdLk\L± Mj«: %D/CEA¥±p <0.05}rj T10 : ¶^·`{¸OT :¶^{¸AUC :[Gz|£H´½]»PL:AR: pre: À¾lpsQR1w: psQ1³¸o2w: psQ2³¸o3w: psQ3³¸o
123
«4-cÃps© ©OZ§ ¼¡{_S VdLk\L ± Mj« PT: 7C/CD4D{¸ (T¦L, 7.4-8.8 s)APTT:qS´P/CD:7?(,D{¸ (T¦L, 12.0-28.8 s)Fibrinogen:56@2E$D (T¦ L, 150-350 mg/dl)D-dimer: D-+;E (T¦L< 2.0 μg/dl)AT: uOZXa (T¦L, 102-156 %)pre: À¾lpsQR1w: psQ1³ ¸o2w: psQ2³¸o3w: psQ3³¸o
124
«4-dé ©OZ§ ¼¡{_S VdLk\L± Mj« PT: 7C/CD4D{¸ (T¦L, 7.4-8.8 s)APTT:qS´P/CD:7?(,D{¸ (T¦L, 12.0-28.8 s)Fibn:56@2E$D (T¦L, 150-350 mg/dl)D-dimer: D-+;E (T¦L< 2.0 μg/dl)AT: uOZXa (T¦L, 102-156%)pre: À¾lpsQR1w: psQ1³¸o 2w: psQ2³¸o3w: psQ3³¸o
125
«4-e.© cN©(CBC) {_S VdLk\L± Mj« WBC:¢©wRBC:¢°©wHGB:8>#C4DlHCT:8;/"@-/LMCV:k\°©fMCH:k\°©8># C4DµMCHC:k\°©8>#C4DlPLT:©hwpre: À¾lpsQR1w: psQ1³¸o2w: psQ2³¸o3wÄ psQ3³¸o
126
«4-f. © ©Sb ¹¬¯ ¡{_S VdLk\L± Mj«BUN:©"B,1DlCre:©ilALT:©?1D<2/?D(5 ?E )lTP:©¢*D3"lAlb:©A6<DlNaÄ©0/@=lKÄ©!@=lClÄ©"CEAlpre: À ¾lpsQR1w: psQ1³o2w: psQ2³o3wÄpsQ3¸o
127
«4-g. ©[¡{_S VdLk\L± Mj« SAP: U¤~©[(T¦L:144 ± 27 mmHg)MAP:k\©[(T¦L:110 ± 21 mmHg)DAP:vn~©[(T¦L:91 ± 20 mmHg)pre: À¾lps QR1w: psQ1³¸o2w: psQ2³¸o3w: psQ3³¸o
128
Ÿ4ŷ ǝǚøăď®ŏŕGŞ,ĕƖķņť7Ʀ
Ǣ ĕƖëIJƕQvfbRut6ADĕƖķņť7Ʀ
129
1. Ƅơ
¸ť61Af6ACîď¦6ŝ&,Ɩķ8ĮƮŧ68gKhsxƖķ
5Ďª2DǔƏƖķ2D,>ǕûƑć Ť7ĕƖķťŇ6Nj%18ĂİA CwzgIsxŹ7ĕ¨ÐƕŞBEǡ9395Ǣ*7ī´ć?Ű$E1Dǡ Ǣ{ĦĕƖëIJƕ2DJYfsx@QvfbRut7 Ť6ê'DĕƖķ
´Ĵ7īŞć8Ű$E1B(JYfsx6ADņť´Ĵ8irZk6Ń;1 Ǡ ŵø7ē634</1DǡǢ%% ĈƋ2§µƏţĈGŦ%1DƖ ķsYQǝĈƋ618ĕ¨Ðƕ3ĕƖëIJƕ2DJYfsx@QvfbR ut7ŞťŇĄƛ35D×Æ?Dǡ Ǣ
ظť6"DƖķÿĎ6Nj%18*7ľ÷@ƖķĎª6Nj'DÖÉì5!ĩ B285<,ŕ7ݵƏƖķŤ6ê'Dņť3%18ĕ¨Ðƕ@ĕƖëIJ ƕ7ŞÖÉ$E1Dǡ813Ǣ*72JYfsx@QvfbRut´
ĴGŰ%,3ÖÉ?ƨ>BE1Dǡ8, 9, 12ǢJYfsx8ǝŞǃ28ƖëIJ ēŞGŰ'ivY[RrxXxI2 (PGI2) ?Ǎç%1%<3őǡJYfsx XuxlǢƍƐǏç547±Ş7ƟőBƴõ28P2Y12ÀèGǍç'DQ vfbRutńŞ$EDA65/1 ,ǡ114Ǣ
Ÿ5ŷ7\t_dsx7ŭŶ28ăď¦61®ŏā1Ƹũ<28¨ÐʼnćGē
'D#3ÂƎ2/,*7ā7¨ÐƹGēD#3©İ5/,*7Ŝ ş3%1Įp`tŕ618AfŖċěƂ%ăďľƎ7}?ƃě$E,#3 2Çƿ27Ɩŋ/ñǂø2/,?73Ġå%,<,Ÿ ŷ7ČćĬA :ĆćĬ7ſĴBƖķÿĎĪ68ƖëIJ7ʼnć?ůƨ2 ,,>Ÿ5ŷ2ƿ7ŭ Ŷ3%18Ÿ3ŷ7ČćĬ7æǜGêœƈǡTxavztƈǢ3%1ĕƖëIJƕ2 DQvfbRutGĔ'DǡQvfbRutƈǢ#32ŕ7AfĪ7ƖķÿĎ¢
È6ê'Dăď¦3ĭĺƿ6"Dĕ¨ÐŞGT-TASGŞ%1Ʃ;D#33%
,
130
2. ĦŇ
22-1. P L b r L x 7 Ƽ ã
ĮŭŶ8ı ƲíÝâµŔæǜŜƝå6ŎĘ%ƺƗ%,ǡĒƨšÄǦŸ ÄǢ
2-2. ƧµŔ
Ÿ2ŷ3Çļ6 ùŧ2D3ƥĥ%,æǜŞezRtŕ15ǘGƧ%,Ÿ3 ŷ7ČćĬ2Ş,ŕ8ǘGTxavztƈ3%łC7ǘGQvfbRutƈ3%, QvfbRutƈ28ć¬8ǐ7ǘA:ǒ8ǘ(0õǟ81Ǩ5ŁǟǡÞ
Ǧ 2ŁǟǢǂ88.6Ǩ12.0 kgǡÞǦ10.2 kgǢ2/,
2-3. Afp`tŕ7Ď
Ÿ2ŷ3Çļ7ĦŇGŞ1ezRtŕ15ǘ6¥ưǞǀ}2ăÛƑjzYozO zszbGÕ>ƳH-*7ājzYozOzszbGÛü®ŏƚƇ6ğƂ%2
mV390 bpm61ǝǚøăď®ŏGƗ#EGAfp`t3%,
2-4. Ĕ ƕ °
QvfbRutƈ28Af ljßĪBƁƂŧ6ĕƖëIJƕ2DQvfbRutǡQ vfbRutŮǁØDž ire^QY®Dž75 mg : VcgKĸüűı ǢG4 mg/kg, SIDǡ16ĪǢžÁĔ2ĔƕGljß%,Ĕǃ6Nj%18Smith, S.A. (2012).
Antithrombotic therapy. Top. Companion. Anim. Med. 27, 8894.ǡ107ǢG¼Ɗ6ƕŞǃG Ņå%,
2-5Ǥ æ ǜ i v a T z t
Ÿ2ŷ3Çļ7ĦŇGŞ1ĐƘ7ĀǖGƊč%110ĨNJ7ƘāťǛĬNJGƤ"
,Ÿ3ŷ7ČćĬ2Ş,ŕ8ǘGTxavztƈǡŒĔƕƈǢ3%,{ĦQv
131 fbRutƈ28łC7ǘ6Afljß3ÇĪ6QvfbRutǡQvfbRutŮǁ ØDž ire^QY®Dž75 mg : VcgKĸüűı ǢG4 mg/kg, SIDǡ16ĪǢž ÁĔ2ĔƕGljß%,ǝǚøăď®ŏ¯ (Pre)®ŏljß1Ƹā (1w)2Ƹā (2w) A:3Ƹā (3w)7ÅĪő61}ƣ7ĐŇ6A/1T-TASĻĵƖŋ¨ÐľƎ ĻĵA:ƖŋĻĵGæħ%,ǡÏ4-aǢ
22-6. Ļ ĵ
2-6-1Ǥ Ğ Ɩ Ħ Ň
Ÿ3ŷ3Çļ7ĦŇGŞ1ƈ7Afp`tŕ6¥ưǞǀ}615Fr7 ĶǛO_z_tGǙǔƏACĝ¤%Xƅƶƞ}2ƇGůƨ%5BÃăď<2O _z_tGƹ>,O_z_tACÃăď¦7ƖŋGĞ¿%,?7GăďƖ3%, ÇǞǀį}61Û¡ÒǔƏAC20 GƉŖDŽGŞ1ĞƖ%,?7GĭĺƖ 3%,
2-6-2ǤT-TASĻ ĵ
Ÿ3ŷ7ČćĬ3Çļ7ĞƖĦŇ6A/1ĞƖ%,ăďƖA:ĭĺƖGŞ
1T-TASĻĵ6ACƖŋ¨ÐƎ3ƖëIJľƎGōå%,ōåĦŇ8Ÿ3ŷ7Č
ćĬ3Çļ7ĦŇ2ōå%,
2-6-3Ǥ Ɩ ŋ ¨ Ð Ļ ĵ
Ÿ3ŷ7ČćĬ3Çļ7ĦŇ6A/1|ƣ2ĞƖ%,ăďƖA:ĭĺƖ GŞ,ivavxexĪNJǡPTǢʼnć·ƿªavxkirY]xĪNJǡAPTTǢ gKhsczSxŐøǡFibnǢD-\LlzǡD-dimerǢA:ĕ¨ÐÍàATG ōå%,
132
Ɩ Ñ Ļ ĵ
Ÿ3ŷ7ČćĬ3Çļ6NWvoas^QŇ6ACƖÑōåGæħ%,¾ƆĬµ ƏÑǡSAP ; systolic arterial blood pressureǢôÓµƏÑǡMAP ; mean arterial blood pressureǢA:ęýĬµƏÑǡDAP ; diastolic arterial blood pressureǢGǥÌƢō%
*7ôÓG?/1ōå3%,Pre1w2wA:3w7ÅĪő61Û ü®ŏƚƇ6AD®ŏG{øĿ%30ªžƻā6ōåGæħ%,
2-6-3Ǥ ƀ Ƣ Ơ ij
ōå8ôÓĽŎï2Ű%,ÅĪő6"DƢōŀƝªð%1D4 Gůƨ'D,>7ŀƝůřiv^aGĎ%WqfvyMKtQĻåA:Tt pUvgyYmtcgĻåGŞ1ªð7ŀƝć7ĻåGƗ/,
`z[ŀƝªð'D×Æ8Two-way ANOVAGƗīĊïáÒ%,×Æ6 1Tukeys test6ACÜǂŃƱGƗ/,ŀƝªð%5×Æ68
Mann-Whitney U TestGƗWilcoxon signed-rank test with Bonferroni correction 6A/1ÜǂŃƱGƗ/,p<0.05GƀƢâŧ6īĊ2D3«ĥ%,īĊï8T xavztƈ3QvfbRutƈ7ƈNJ6"DīĊï7=GŰ%,
3. ſĴ
3-1. T-TASĻ ĵ
(a) ăďƖ
QvfbRutƈ7ăďƖ7AR]^i28Txavztƈ3Çļ7ĠŴGŰ%, AR]^i7T10OTA:AUC28(E?Txavztƈ3ŃƱ%11w 2w3w7*E+E61īĊ5Ú·8ƨ>BE5/,ǡÏ4-gǢǡƙ4-hǢăď
133 Ɩ7PL]^i7T10OT28Txavztƈ3ŃƱ%1úLJ¢ÈAUC28Ōì
¢Èƨ>BE,1w2w3w7*E+E61īĊ5Ú·8ƨ>BE5/
,ǡÏ4-hǢǡƙ4-hǢ
(b)ĭĺƖ
QvfbRutƈ7ĭĺƖ7AR]^i28T10OTA:AUC618Tx avztƈ3ŃƱ%11w2w3w7*E+E61?īĊ5Ú·8ƨ>BE 5/,ǡÏ4-iǢǡƙ4-iǢQvfbRutƈ7ĭĺƖ7PL]^i618T10 OT8Txavzt3ŃƱ%11w2w3w7*E+E61īĊ6úLJ%
AUC8īĊ6Ōì%,ǡpǧ0.01ǢǡÏ4-jǢǡƙ4-iǢ
33-2. Ɩ ŋ ¨ Ð ľ Ǝ Ļ ĵ
(a) ăďƖ
QvfbRutƈ7ăďƖ618Txavztƈ3ŃƱ%11w2w3w 7*E+E61īĊ5Ú·8ƨ>BE5/,<,(E?¼Ɗ7ŽÎ¦2 7Ú·2/,ǡ¼Ɗ PTǦ7.4ųǨ8.8ųAPTTǦ12.0Ǩ28.8ųFibnǦ150Ǩ 350 mgǢǡƙ4-jǢ
(b) ĭĺƖ
QvfbRutƈ7ĭĺƖ618Txavztƈ3ŃƱ%11w2w3w 7*E+E61īĊ5Ú·8ƨ>BE5/,<,(E?¼Ɗ7ŽÎ¦2 7Ú·2/,ǡ¼Ɗ PTǦ7.4ųǨ8.8ųAPTTǦ12.0Ǩ28.8ųFibnǦ150Ǩ 350 mgǢǡƙ4-kǢ
3-3Ǥ Ɩ ŋ Ļ ĵ
134 33-3-1Ǥ ä ¥ Ɩ ś Ƣ Ż ǡCBCǢ
QvfbRutƈ28Txavztƈ3ŃƱ%1(E7Ǘũ61?īĊ5 Ú·8=BE5/,ǡƙ4-lǢ
3-3-2Ǥ Ɩ ŋ · â Ļ ĵ A : Ǔ Ơ Ʈ Ļ ĵ
QvfbRutƈ28Txavztƈ3ŃƱ%1(E7Ǘũ61?īĊ5 Ú·8=BE5/,ǡƙ4-mǢ
3-4Ǥ Ɩ Ñ Ļ ĵ
QvfbRutƈ28SAPMAPA:DAP(E61?Txavztƈ 3ŃƱ%1(E7Ǘũ61?īĊ5Ú·8=BE5/,ǡƙ4-nǢ